Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU- rich elements: Implications for joint and gut-associated immunopathologies

Immunity

Volumn 10, Issue 3, 1999, Pages 387-398

  Kontoyiannis, Dimitris ^a   Pasparakis, Manolis ^a,c   Pizarro, Theresa T ^b   Cominelli, Fabio ^b   Kollias, George ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTHRITIS; ARTICLE; ENTERITIS; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MOUSE; NEGATIVE FEEDBACK; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN INDUCTION; REGULATORY MECHANISM; RNA TRANSLATION; T LYMPHOCYTE;

EID: 0033103805     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80038-2     Document Type: Article

References (53)

1. Alexopoulou, L., Pasparakis, M., and Kollias, G. (1997). A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur. J. Immunol. 27, 2588-2592.
2. Araki, K., Araki, M., Miyazaki, J., and Vassalli, P. (1995). Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc. Natl. Acad. Sci. USA 92, 160-164.
3. Beutler, B., Krochin, N., Milsark, I.W., Luedke, C., and Cerami, A. (1986). Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 232, 977-980.
4. Brennan, F.M., Chantry, D., Jackson, A., Maini, R., and Feldmann, M. (1989). Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244-247.
5. Brown, C.R., Nakamura, M.S., Mosca, J.D., Hayward, G.S., Straus, S.E., and Perera, L.P. (1995). Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3′ ends of labile mRNA. J. Virol. 69, 7187-7195.
6. Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., and Cerami, A. (1986). Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83, 1670-1674.
7. Carballo, E., Lai, W.S., and Blackshear, P.J. (1998). Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281, 1001-1005.
8. Chen, C.Y., and Shyu, A.B. (1995). AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem. Sci. 20, 465-470.
9. Chen, C.Y., Del Gatto-Konczak, F., Wu, Z., and Karin, M. (1998). Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280, 1945-1949.
10. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
11. Collart, M.A., Baeuerle, P., and Vassalli, P. (1990). Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol. 10, 1498-1506.
12. Douni, E., Akassoglou, K., Alexopoulou, L., Georgopoulos, S., Haralambous, S., Hill, S., Kassiotis, G., Kontoyiannis, D., Pasparakis, M., Plows, D., et al. (1995). Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J. Inflamm. 47, 27-38.
13. Elliott, M.J., Maini, R.N., Feldmann, M., Long-Fox, A., Charles, P., Bijl, H., and Woody, J.N. (1994). Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344, 1125-1127.
14. Erickson, S.L., de Sauvage, F.J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K.C., Schreiber, R.D., Goeddel, D.V., and Moore, M.W. (1994). Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372, 560-563.
15. Goldfeld, A.E., Strominger, J.L., and Doyle, C. (1991). Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines. J. Exp. Med. 174, 73-81.
16. Grell, M., Douni, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., and Pfizenmaier, K. (1995). The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83, 793-802.
17. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H., and Rajewsky, K. (1994). Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106.
18. Hambleton, J., McMahon, M., and DeFranco, A.L. (1995). Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events. J. Exp. Med. 182, 147-154.
19. Han, J., Brown, T., and Beutler, B. (1990). Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171, 465-475.
20. Han, J., Huez, G., and Beutler, B. (1991a). Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J. Immunol. 146, 1843-1848.
21. Han, J.H., Beutler, B., and Huez, G. (1991b). Complex regulation of tumor necrosis factor mRNA turnover in lipopolysaccharide-activated macrophages. Biochim. Biophys. Acta 1090, 22-28.
22. Jacob, C.O., Lee, S.K., and Strassmann, G. (1996). Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J. Immunol. 156, 3043-3050.
23. Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., and Kollias, G. (1991). Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J. 10, 4025-4031.
24. Kruys, V., Marinx, O., Shaw, G., Deschamps, J., and Huez, G. (1989). Translational blockade imposed by cytokine-derived UA-rich sequences. Science 245, 852-855.
25. Kruys, V., Thompson, P., and Beutler, B. (1993). Extinction of the tumor necrosis factor locus, and of genes encoding the lipopolysaccharide signaling pathway. J. Exp. Med. 177, 1383-1390.
26. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
27. Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, D., Blumenthal, M.J., Heys, J.R., and Landvatter, S.W. (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746.
28. Lieberman, A.P., Pitha, P.M., and Shin, M.L. (1990). Protein kinase regulates tumor necrosis factor mRNA stability in virus-stimulated astrocytes. J. Exp. Med. 172, 989-992.
29. Linial, M., Gunderson, N., and Groudine, M. (1985). Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science 230, 1126-1132.
30. Mombaerts, P., Iacomini, J., Johnson, R.S., Herrup, K., Tonegawa, S., and Papaioannou, V.E. (1992). RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877.
31. Moreira, A.L., Sampaio, E.P., Zmuidzinas, A., Frindt, P., Smith, K.A., and Kaplan, G. (1993). Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177, 1675-1680.
32. Neurath, M.F., Fuss, I., Pasparakis, M., Alexopoulou, L., Haralambous, S., Meyer zum Buschenfelde, K., Strober, W., and Kollias, G. (1997). Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol. 27, 1743-1750.
33. Pasparakis, M., and Kollias, G. (1995). Production of cytokine transgenic and knockout mice. In Cytokines: A Practical Approach, F.R. Balkwill, ed. (New York: Oxford University Press), pp. 297-325.
34. Pasparakis, M., Alexopoulou, L., Douni, E., and Kollias, G. (1996a). Tumour necrosis factors in immune regulation: Everything that's interesting is...new! Cytokine Growth Factor Rev. 7, 223-229.
35. Pasparakis, M., Alexopoulou, L., Episkopou, V., and Kollias, G. (1996b). Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397-1411.
36. Peng, S.S., Chen, C.Y., Xu, N., and Shyu, A.B. (1998). RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17, 3461-3470.
37. Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L., and Kriegler, M. (1990). A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63, 251-258.
38. Powrie, F. (1995). T cells in inflammatory bowel disease: Protective and pathogenic roles. Immunity. 3, 171-174.
39. + T cells. Immunity. 1, 553-562.
40. Prichett, W., Hand, A., Sheilds, J., and Dunnington, D. (1995). Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor alpha. J. Inflamm. 45, 97-105.
41. Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., and Bluethmann, H. (1993). Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798-802.
42. Santee, S.M., and Owen-Schaub, L.B. (1996). Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J. Biol. Chem. 271, 21151-21159.
43. Shull, M.M., Ormsby, I., Kier, A.B., Pawlowski, S., Diebold, R.J., Yin, M., Allen, R., Sidman, C., Proetzel, G., and Calvin, D. (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
44. Strober, W., Fuss, I.J., Ehrhardt, R.O., Neurath, M., Boirivant, M., and Ludviksson, B.R. (1998). Mucosal immunoregulation and inflammatory bowel disease: New insights from murine models of inflammation. Scand. J. Immunol. 48, 453-458
45. Swantek, J.L., Cobb, M.H., and Geppert, T.D. (1997). Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol. Cell. Biol. 17, 6274-6282.
46. Targan, S.R., Hanauer, S.B., van Deventer, S.J., Mayer, L., Present, D.H., Braakman, T., DeWoody, K.L., Schaible, T.F., and Rutgeerts, P.J. (1997). A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease cA2 study group. N. Engl. J. Med. 337, 1029-1035.
47. Taylor, G.A., Carballo, E., Lee, D.M., Lai, W.S., Thompson, M.J., Patel, D.D., Schenkman, D.I., Gilkeson, G.S., Broxmeyer, H.E., Haynes, B.F., and Blackshear, P.J. (1996). A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity. 4, 445-454.
48. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
49. van Deventer, S.J. (1997). Tumour necrosis factor and Crohn's disease. Gut 40, 443-448.
50. Vandenabeele, P., Declercq, W., Beyaert, R., and Fiers, W. (1995). Two tumor necrosis factor receptors: Structure and function. Trends Cell Biol. 5, 392-399.
51. Vassalli, P. (1992). The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411-452.
52. Warren, M.K., and Vogel, S.N. (1985). Bone marrow-derived macrophages: Development and regulation of differentiation markers by colony-stimulating factor and interferons. J. Immunol. 134, 982-989.
53. Yang, Y., Chang, J.F., Parnes, J.R., and Fathman, C.G. (1998). T cell receptor (TCR) engagement leads to activation-induced splicing of tumor necrosis factor (TNF) nuclear pre-mRNA. J. Exp. Med. 188, 247-254.